An in vitro model for exploring CR theophylline-milk fat interactions

Abstract The dissolution of the controlled-release theophylline formulations, Theodur tablet and Theodur sprinkle capsule, was studied in buffer of pH 6.5 and in milk with varying fat contents i.e. 0.1%, 2.0%, 5.0% and 7.5%. The topographical dissolution characterization made was based on a three-dimensional format with independent variables, time and percent fat content of milk. This plot revealed that the dissolution of capsule was markedly lower in all types of milk than in buffer. The dissolution of tablet was higher in milk with 0.1% fat content and slightly higher in milk with 2.0% and 5.0% fat content when compared to that in buffer. The dissolution of tablet in milk with 7.5% fat content was initially lower and then became progressively faster than observed in the aqueous medium. Binding experiments of theophylline to milk with 0.1% and 2.0% fat content, using concentrations encountered during the dissolution process, showed no significant interaction between theophylline and milk. The dissolution data clearly indicate a milk fat content dependent interaction between theophylline formulations and milk. In vivo data reported in literature and observed under “high fat meal” conditions were correlated with the dissolution data. Linear correlations were established in all cases. It was concluded that the 7.5% fat content milk mimics more closely the “high fat meal” conditions. This would aid the development of an appropriate dissolution test capable of simulating non-fasting conditions.

[1]  Michael A. Koupparis,et al.  Dissolution of 4 controlled-release theophylline formulations in milk , 1987 .

[2]  S. Pedersen,et al.  Delay in the absorption rate of theophylline from a sustained release theophylline preparation caused by food. , 1981, British journal of clinical pharmacology.

[3]  P. Welling,et al.  Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects. , 1983, Biopharmaceutics & drug disposition.

[4]  A. Karim,et al.  Food‐induced changes in theophylline absorption from controlled‐release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo‐Dur Sprinkle , 1985, Clinical pharmacology and therapeutics.

[5]  P E Macheras,et al.  Effect of temperature and fat content on the binding of hydrochlorothiazide and chlorothiazide to milk. , 1988, Journal of pharmaceutical sciences.

[6]  L Hendeles,et al.  Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity. , 1985, Chest.

[7]  R. A. Zeeuw,et al.  A new in vitro dissolution test for controlled-release theophylline tablets , 1981 .

[8]  Topographical Dissolution Characterization for Controlled Release Products - a New Technique , 1986 .

[9]  L. Hendeles,et al.  A Clinical and Pharmacokinetic Basis for the Selection and Use of Slow Release Theophylline Products , 1984, Clinical pharmacokinetics.

[10]  Z. Shihabi Emergency gas-chromatographic assay of phenobarbital and phenytoin and liquid-chromatographic assay of theophylline. , 1978, Clinical chemistry.

[11]  P. Maturu,et al.  Influence of a high fat breakfast on the bioavailability of theophylline controlled-release formulations: an in vitro demonstration of an in vivo observation. , 1986, Journal of pharmaceutical sciences.

[12]  A. Leo,et al.  Substituent constants for correlation analysis in chemistry and biology , 1979 .

[13]  S. K. Ratkje,et al.  Drug distribution within human milk phases. , 1985, Journal of pharmaceutical sciences.

[14]  S. Pedersen,et al.  Erratic absorption of a slow-release theophylline sprinkle product. , 1984, Pediatrics.